Ole Jensen

发表

Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans

J. Brockmöller, M. Tzvetkov, M. Schwab, 2020, Clinical pharmacology and therapeutics.

Overlap and Specificity in the Substrate Spectra of Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3

J. Brockmöller, Ole Jensen, L. Gebauer, 2021, International journal of molecular sciences.

OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil

J. Brockmöller, T. Prukop, M. Tzvetkov, 2018, Clinical pharmacology and therapeutics.

Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.

J. Brockmöller, M. Tzvetkov, Muhammad Rafehi, 2019, Biochemical pharmacology.

The mystery of the human proton-organic cation antiporter: One transport protein or many?

J. Brockmöller, Alexandra Sachkova, Ole Jensen, 2022, Pharmacology & therapeutics.

Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.

J. Puchalka, W. Al-Herz, C. Klein, 2012, Gastroenterology.

Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A

F. Faltraco, J. Brockmöller, T. Prukop, 2019, Front. Pharmacol..

Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?

J. Brockmöller, Muhammad Rafehi, Ole Jensen, 2021, Frontiers in Pharmacology.

Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.

J. Brockmöller, Ole Jensen, L. Gebauer, 2022, Journal of medicinal chemistry.

Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities

J. Brockmöller, Alexandra Sachkova, Ole Jensen, 2022, International journal of molecular sciences.

Combined and independent effects of OCT1 and CYP2D6 on the cellular disposition of drugs.

J. Brockmöller, Ole Jensen, L. Gebauer, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Atypical Substrates of the Organic Cation Transporter 1

J. Brockmöller, Ole Jensen, L. Gebauer, 2022, Biomolecules.

Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1

J. Brockmöller, Ole Jensen, L. Gebauer, 2022, International journal of molecular sciences.

Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients

S. Leucht, J. Brockmöller, M. Tzvetkov, 2021, Frontiers in Pharmacology.

Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport

J. Brockmöller, M. Tzvetkov, J. Matthaei, 2021, Frontiers in Pharmacology.

Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.

J. Brockmöller, Ole Jensen, Christof Dücker, 2021, Journal of medicinal chemistry.

A double-Flp-in method for stable overexpression of two genes

J. Brockmöller, M. Tzvetkov, J. Geyer, 2020, Scientific Reports.

CTLA-4 Genetic Variants Predict Survival in Patients with Sepsis

S. Shen-Orr, T. Beißbarth, J. Hinz, 2019, Journal of clinical medicine.

Bioengineering of a human innervated cardiac muscle model

S. Sakib, Ole Jensen, A. Fischer, 2023, bioRxiv.

Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.

Muhammad Rafehi, Ole Jensen, L. Gebauer, 2021, Biochemical pharmacology.

Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters

Muhammad Rafehi, Ole Jensen, L. Gebauer, 2023, Molecular pharmaceutics.